FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104507637> ?p ?o ?g. }

• W2104507637 endingPage "d7222" @default.
• W2104507637 startingPage "d7222" @default.
• W2104507637 abstract "<b>Objectives </b>To test whether bisphosphonate use is related to improved implant survival after total arthroplasty of the knee or hip. <b>Design</b> Population based retrospective cohort study. <b>Setting</b> Primary care data from the United Kingdom. <b>Participants</b> All patients undergoing primary total arthroplasty of the knee (n=18 726) or hip (n=23 269) in 1986-2006 within the United Kingdom’s General Practice Research Database. We excluded patients with a history of hip fracture before surgery or rheumatoid arthritis, and individuals younger than 40 years at surgery. <b>Intervention</b> Bisphosphonate users were classified as patients with at least six prescriptions of bisphosphonates or at least six months of prescribed bisphosphonate treatment with more than 80% adherence before revision surgery. <b>Outcome measures</b> Revision arthroplasties occurring after surgery, identified by READ and OXMIS codes. Parametric survival models were used to determine effects on implant survival with propensity score adjustment to account for confounding by indication. <b>Results </b>Of 41 995 patients undergoing primary hip or knee arthroplasty, we identified 1912 bisphosphonate users, who had a lower rate of revision at five years than non-users (0.93% (95% confidence interval 0.52% to 1.68%) <i>v</i> 1.96% (1.80% to 2.14%)). Implant survival was significantly longer in bisphosphonate users than in non-users in propensity adjusted models (hazard ratio 0.54 (0.29 to 0.99); P=0.047) and had an almost twofold increase in time to revision after hip or knee arthroplasty (time ratio 1.96 (1.01 to 3.82)). Assuming 2% failure over five years, we estimated that the number to treat to avoid one revision was 107 for oral bisphosphonates. <b>Conclusions </b>In patients undergoing lower limb arthroplasty, bisphosphonate use was associated with an almost twofold increase in implant survival time. These findings require replication and testing in experimental studies for confirmation." @default.
• W2104507637 created "2016-06-24" @default.
• W2104507637 creator A5000914971 @default.
• W2104507637 creator A5018103276 @default.
• W2104507637 creator A5030613053 @default.
• W2104507637 creator A5049564443 @default.
• W2104507637 creator A5057334780 @default.
• W2104507637 creator A5058622525 @default.
• W2104507637 creator A5086010333 @default.
• W2104507637 date "2011-12-06" @default.
• W2104507637 modified "2023-10-15" @default.
• W2104507637 title "Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study" @default.
• W2104507637 cites W1852065298 @default.
• W2104507637 cites W1977038221 @default.
• W2104507637 cites W1989249211 @default.
• W2104507637 cites W1993231267 @default.
• W2104507637 cites W1995610721 @default.
• W2104507637 cites W1999793317 @default.
• W2104507637 cites W2006439096 @default.
• W2104507637 cites W2006452622 @default.
• W2104507637 cites W2011823975 @default.
• W2104507637 cites W2035777306 @default.
• W2104507637 cites W2040492681 @default.
• W2104507637 cites W2065153076 @default.
• W2104507637 cites W2074361851 @default.
• W2104507637 cites W2084292255 @default.
• W2104507637 cites W2084917404 @default.
• W2104507637 cites W2100165425 @default.
• W2104507637 cites W2113167608 @default.
• W2104507637 cites W2113958163 @default.
• W2104507637 cites W2128046371 @default.
• W2104507637 cites W2135327653 @default.
• W2104507637 cites W2138211812 @default.
• W2104507637 cites W2141028812 @default.
• W2104507637 cites W2141976431 @default.
• W2104507637 cites W2150291618 @default.
• W2104507637 cites W2150651101 @default.
• W2104507637 cites W2152775198 @default.
• W2104507637 cites W2157979607 @default.
• W2104507637 cites W2168284540 @default.
• W2104507637 cites W2171653148 @default.
• W2104507637 cites W2319424675 @default.
• W2104507637 cites W2171119558 @default.
• W2104507637 cites W2336274323 @default.
• W2104507637 doi "https://doi.org/10.1136/bmj.d7222" @default.
• W2104507637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3232250" @default.
• W2104507637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22147909" @default.
• W2104507637 hasPublicationYear "2011" @default.
• W2104507637 type Work @default.
• W2104507637 sameAs 2104507637 @default.
• W2104507637 citedByCount "100" @default.
• W2104507637 countsByYear W21045076372012 @default.
• W2104507637 countsByYear W21045076372013 @default.
• W2104507637 countsByYear W21045076372014 @default.
• W2104507637 countsByYear W21045076372015 @default.
• W2104507637 countsByYear W21045076372016 @default.
• W2104507637 countsByYear W21045076372017 @default.
• W2104507637 countsByYear W21045076372018 @default.
• W2104507637 countsByYear W21045076372019 @default.
• W2104507637 countsByYear W21045076372020 @default.
• W2104507637 countsByYear W21045076372021 @default.
• W2104507637 countsByYear W21045076372022 @default.
• W2104507637 countsByYear W21045076372023 @default.
• W2104507637 crossrefType "journal-article" @default.
• W2104507637 hasAuthorship W2104507637A5000914971 @default.
• W2104507637 hasAuthorship W2104507637A5018103276 @default.
• W2104507637 hasAuthorship W2104507637A5030613053 @default.
• W2104507637 hasAuthorship W2104507637A5049564443 @default.
• W2104507637 hasAuthorship W2104507637A5057334780 @default.
• W2104507637 hasAuthorship W2104507637A5058622525 @default.
• W2104507637 hasAuthorship W2104507637A5086010333 @default.
• W2104507637 hasBestOaLocation W21045076371 @default.
• W2104507637 hasConcept C126322002 @default.
• W2104507637 hasConcept C141071460 @default.
• W2104507637 hasConcept C167135981 @default.
• W2104507637 hasConcept C17923572 @default.
• W2104507637 hasConcept C201903717 @default.
• W2104507637 hasConcept C207103383 @default.
• W2104507637 hasConcept C2776541429 @default.
• W2104507637 hasConcept C2777251235 @default.
• W2104507637 hasConcept C2778336525 @default.
• W2104507637 hasConcept C2778885795 @default.
• W2104507637 hasConcept C2781411149 @default.
• W2104507637 hasConcept C2908647359 @default.
• W2104507637 hasConcept C44249647 @default.
• W2104507637 hasConcept C50382708 @default.
• W2104507637 hasConcept C71924100 @default.
• W2104507637 hasConcept C72563966 @default.
• W2104507637 hasConcept C99454951 @default.
• W2104507637 hasConceptScore W2104507637C126322002 @default.
• W2104507637 hasConceptScore W2104507637C141071460 @default.
• W2104507637 hasConceptScore W2104507637C167135981 @default.
• W2104507637 hasConceptScore W2104507637C17923572 @default.
• W2104507637 hasConceptScore W2104507637C201903717 @default.
• W2104507637 hasConceptScore W2104507637C207103383 @default.
• W2104507637 hasConceptScore W2104507637C2776541429 @default.
• W2104507637 hasConceptScore W2104507637C2777251235 @default.
• W2104507637 hasConceptScore W2104507637C2778336525 @default.

• next